Anti-Human IFNA1 Recombinant Antibody(Sifalimumab)

Product Information

Catalog Number	YR1217
Product Name	Anti-Human IFNA1 Recombinant Antibody(Sifalimumab)
Molecular Name	Sifalimumab
Alias	Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab
CAS Number	1006877-41-3
Target	IFNA1[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab was developed by MedImmune, as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price